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Simple Summary: Reindeer are an important wild and domesticated species of the Arctic, Northern
Europe, Siberia and North America. As reindeer have developed various strategies to adapt to
extreme environments, this makes them an interesting species for studies into diversity of immune
and metabolic functions in the animal kingdom. Importantly, while reindeer carry natural infections
caused by viruses (including coronaviruses), bacteria and parasites, they can also act as carriers
for transmitting such diseases to other animals and humans, so called zoonosis. Reindeer are also
affected by chronic wasting disease, a neuronal disease caused by prions, similar to scrapie in sheep,
mad cows disease in cattle and Creutzfeldt-Jakob disease in humans. The current study assessed
a specific protein modification called deimination/citrullination, which can change how proteins
function and allow them to take on different roles in health and disease processes. Profiling of
deiminated proteins in reindeer showed that many important pathways for immune defenses, prion
diseases and metabolism are enriched in deiminated proteins, both in plasma, as well as in plasma
extracellular vesicles. This study provides a platform for the development of novel biomarkers to
assess wild life health status and factors relating to zoonotic disease.
Abstract: The reindeer (caribou) Rangifer tarandus is a Cervidae in the order Artiodactyla. Reindeer
are sedentary and migratory populations with circumpolar distribution in the Arctic, Northern
Europe, Siberia and North America. Reindeer are an important wild and domesticated species, and
have developed various adaptive strategies to extreme environments. Importantly, deer have also
been identified to be putative zoonotic carriers, including for parasites, prions and coronavirus.
Therefore, novel insights into immune-related markers are of considerable interest. Peptidylarginine
deiminases (PADs) are a phylogenetically conserved enzyme family which causes post-translational
protein deimination by converting arginine into citrulline in target proteins. This affects protein
function in health and disease. Extracellular vesicles (EVs) participate in cellular communication, in
physiological and pathological processes, via transfer of cargo material, and their release is partly
regulated by PADs. This study assessed deiminated protein and EV profile signatures in plasma
from sixteen healthy wild female reindeer, collected in Iceland during screening for parasites and
chronic wasting disease. Reindeer plasma EV profiles showed a poly-dispersed distribution from
30 to 400 nm and were positive for phylogenetically conserved EV-specific markers. Deiminated
proteins were isolated from whole plasma and plasma EVs, identified by proteomic analysis and
protein interaction networks assessed by KEGG and GO analysis. This revealed a large number
of deimination-enriched pathways for immunity and metabolism, with some differences between
whole plasma and EVs. While shared KEGG pathways for whole plasma and plasma EVs included
complement and coagulation pathways, KEGG pathways specific for EVs were for protein digestion
and absorption, platelet activation, amoebiasis, the AGE–RAGE signaling pathway in diabetic
complications, ECM receptor interaction, the relaxin signaling pathway and the estrogen signaling
pathway. KEGG pathways specific for whole plasma were pertussis, ferroptosis, SLE, thyroid
hormone synthesis, phagosome, Staphylococcus aureus infection, vitamin digestion and absorption,
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and prion disease. Further differences were also found between molecular function and biological
processes GO pathways when comparing functional STRING networks for deiminated proteins in
EVs, compared with deiminated proteins in whole plasma. This study highlights deiminated proteins
and EVs as candidate biomarkers for reindeer health and may provide information on regulation of
immune pathways in physiological and pathological processes, including neurodegenerative (prion)
disease and zoonosis.
Keywords: protein deimination/citrullination; peptidylarginine deiminase (PAD); extracellular vesicles
(EVs); reindeer (Rangifer tarandus); immunity; metabolism; gene regulation; prion disease; zoonosis
1. Introduction
The reindeer (Rangifer tarandus), also known as the caribou in North America, is a
mammal of the order Artiodactyla, family Cervidae, and has a circumpolar distribution.
Reindeer play an important role in economy, society, culture and ecological values among
populations of Eurasia and were fundamental for the colonization of the northern part of
Eurasia. They have been a source of food among indigenous culture and were sporadically
used for transportation, and therefore can be considered as a semi-domesticated species [1].
Reindeer are adapted to extreme environments throughout their evolution, exhibiting dis-
tinctive and unique biological characteristics relating to fat metabolism processes, changes
to their internal biological clock, limited heat loss and low resting metabolic rate. However,
the underlying molecular and genetic basis for these traits remains largely unknown [1,2].
The IUCN Red List of Threatened Species (2016) has classified reindeer as a vulnerable
species due to a decline of individuals, possibly attributed to habitat shift and/or their
susceptibility to chronic wasting disease (CWD), a fatal neurodegenerative disorder [3,4].
Importantly also, R. tarandus may play roles in various zoonotic diseases, including para-
sitic, bacterial and viral ones [5–8], and deer have furthermore been recently identified to
be new reservoir hosts for SARS-CoV-2 [9].
While the reindeer genome has been sequenced [10], and genetic diversity and mi-
tochondrial DNA have furthermore been studied [11], no studies have hitherto been
performed into mechanisms relating to post-translational modifications such as deimina-
tion, which is caused by peptidylarginine deiminases (PADs). Furthermore, while research
on extracellular vesicles (EVs) is a major field in relation to biomarker discovery in hu-
man pathologies, and recent comparatives studies have highlighted their value in a range
of wild, domestic and commercially valuable land and aquatic animals throughout the
phylogeny tree [12–25], the field is still in its infancy in relation to studies and biomarker
development in wild animals.
Peptidylarginine deiminases (PADs) are a phylogenetically conserved
calcium-dependent family of enzymes. PADs convert arginine into citrulline in an ir-
reversible manner, leading to post-translational modification (citrullination/deimination)
in numerous target proteins of cytoplasmic, nuclear and mitochondrial origin [17,26–30].
Deimination causes structural protein changes which can affect protein function and
consequently downstream protein–protein interactions. Deimination can, among other,
contribute to neo-epitope generation, which results in inflammatory responses, as well as
affect gene regulation and neutrophil extracellular trap formation (NETosis) via deimina-
tion of histones [31–35]. As post-translational changes contribute to protein moonlighting,
which allows one protein to exhibit different functions within one polypeptide chain [36],
deimination may facilitate such functional diversity of proteins in health and disease.
In mammals, five PAD isozymes are known, while lower in the phylogeny tree, there
is less diversification of PADs, with three PAD isozymes described in birds and reptiles, but
only one PAD form in fish [17,18,26,28,29,37]. Furthermore, PAD homologues, also referred
to as arginine deiminases (ADI) [38] have been described in parasites [39], bacteria [40,41]
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and fungi [42]. This places PADs as important proteins both in host immune defenses, as
well as in host–pathogen interactions.
A majority of studies on PADs and downstream deimination have related to human
pathological mechanisms, but recently a comparative body of research has focused on
identifying putative roles for PADs in physiological and immunological pathways in a
wide range of taxa throughout the phylogenetic tree, including land and sea mammals,
reptiles, birds, bony and cartilaginous fish, Mollusca and Crustacea [16–25,28,29]. PADs
have furthermore been identified to have roles in mucosal, innate and adaptive immunity
in a range of taxa [17–20,25,28,29,43,44]. Importantly, PADs have also been identified as
important players in infection and anti-pathogenic responses, including anti-viral [45,46]
and anti-parasitic ones [39], as well as in anti-bacterial mechanisms [40,41]. Furthermore,
as roles for PADs in EV release and deiminated protein cargo in EVs in health and disease,
in diverse taxa and comparative animal models of disease, are gaining increased attention,
investigations into reindeer may be of some interest.
EV biogenesis and regulation of EV release from cells has been shown to be regulated
by PADs to some extent, and as this has been identified in a range of taxa, it appears
to be a phylogenetically conserved function [39,41,47–50]. EVs participate in cellular
communication and can be isolated from many body fluids, including serum, plasma,
saliva and urine. EVs play physiological and pathological roles via transfer of cargo
proteins and genetic material, including in inflammatory responses, in infection and host–
pathogen interactions [34,39,51–55]. As EVs carry information from their cells of origin,
their cargo signatures are usable biomarkers [56,57]. Currently, as relatively few studies
on EVs have been conducted in wild animals [14,15,25] this is a pioneering and promising
field for novel biomarker discovery and development.
As, to date, neither PADs and associated deimination nor EVs have been assessed
in reindeer, the current study aimed at profiling protein deimination in plasma and
plasma EVs for assessment of regulation on protein networks and identification of putative
biomarkers to gain new insights into both immune system and metabolic adaptations of
reindeer. This study may further current understanding of the roles for post-translational
modifications in functional diversification of conserved proteins throughout phylogeny.
2. Materials and Methods
2.1. Plasma Sampling
Blood samples were taken from sixteen individual female reindeer (R. tarandus)—average
age approximately 7 years (range 1.5–12 years old)—sampled in Iceland. The sampling was
part of research dealing with general health of Icelandic reindeer with specific emphasis on
chronic wasting disease (CWD) and presence of parasites. Sample collection was in accor-
dance with Icelandic laws and regulations on sampling from wild animals (64/1994) and
licenses of the Institute for Experimental Pathology at Keldur, University of Iceland (number
#0001 kt-650269—4549), approved by the central animal ethics committee in Iceland (Icelandic
Food Regulation Authority, MAST Matvælastofnun). The plasma was isolated according to
standard procedures from EDTA blood samples. Brain samples from the same animals were
screened for presence of prion disease by ELISA (TeSeE®, Bio-Rad, UK) following standard
procedures at the Institute for Experimental Pathology at Keldur, and the animals were con-
firmed to be disease free and healthy. Plasma was aliquoted at 250 µL and stored at −80 ◦C
until further use for the individual experiments.
2.2. Isolation of Extracellular Vesicles and Nanoparticle Tracking Analysis (NTA)
Reindeer plasma EVs were prepared from the individual plasma (thawed on ice) of the
sixteen animals using sequential centrifugation and ultracentrifugation. Procedures were
carried out according to our previously standardized and described protocols [18,23,43],
also following recommendations of MISEV2018 (the minimal information for studies of
extracellular vesicles 2018) [58]. For each individual plasma EV preparation, 100 µL of
reindeer plasma was diluted 1:5 in Dulbecco’s PBS (DPBS, ultrafiltered using a 0.22 µm
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filter, before use). This was then centrifuged for 20 min at 4000× g at 4 ◦C, to remove
apoptotic bodies and aggregates. Supernatants were then collected and ultra-centrifuged
at 100,000× g at 4 ◦C for 1 h. This resulted in EV-enriched pellets, which were resuspended
each in 500 µL DPBS and thereafter ultra-centrifuged again for 1 h at 100,000× g, at 4 ◦C.
The final resulting EV pellets were resuspended each in 100 µL of DPBS. The EVs were
kept frozen at −80 ◦C until used in the procedures described below (all assessments were
performed with EV preparations that had not been frozen for longer than 1 week). Plasma
EV size distribution profiles were generated and EVs were quantified using nanoparticle
tracking analysis (NTA), based on Brownian motion of particles in suspension, and carried
out using the NanoSight NS300 system (Malvern Panalytical Ltd., Malvern, UK). Prior
to application on the NanoSight, the EV samples were diluted 1/100 in DPBS (10 µL of
EV preparation diluted in 990 µL of DPBS). The diluted EV samples were applied to the
NanoSight NS300 (Malvern Panalytical, UK), recording four repetitive reads, 60 sec each.
Particle numbers per frame were 40 to 60, camera settings were at level 12 for recording
and for post-analysis the threshold was set at 3. Replicate histograms were generated
from these videos using the NanoSight software 3.0 (Malvern), representing mean and
confidence intervals of the four recordings for each sample.
2.3. Transmission Electron Microscopy (TEM)
Plasma EVs were assessed for morphology using TEM, using a pool of plasma EVs
from five animals. The procedure was similar as previously described [16,20]. Following
thawing of isolated EV pellets (stored frozen for 1 week before imaging), the EVs were
resuspended in 100 mM sodium cacodylate buffer (pH 7.4). One drop (~3–5 µL) of the
EV suspension was placed onto a grid which held a carbon support film which had been
previously glow-discharged. Following partial drying of the EV suspension, the sample
was fixed for 1 min at room temperature by placing the grid onto a drop of a fixative solution
(2.5% glutaraldehyde in 100 mM sodium cacodylate buffer (pH 7.0)). The grid was applied
to the surface of three drops of distilled water for washing of the EV sample, removing
excess water using a filter paper. The EVs were then stained for 1 min with 2% aqueous
Uranyl Acetate (Sigma-Aldrich), removing excess stain with a filter paper and air drying
the grid. TEM imaging of EVs was carried out with a JEOL JEM 1400 transmission electron
microscope (JEOL, Tokyo, Japan), which was operated at 80 kV, using a magnification of
30,000× to 60,000×. Recording of digital images was performed with an AMT XR60 CCD
camera (Deben, UK).
2.4. Isolation of Deiminated Proteins Using F95 Enrichment
Total deiminated proteins were isolated from reindeer plasma and plasma EVs using
the F95 pan-deimination antibody (MABN328, Merck, UK) and the Catch and Release®v2.0
immunoprecipitation kit (Merck), according to previously described methods in a range of
taxa [16,18,20,23,43]. The F95-antibody specifically detects proteins modified by citrullina-
tion and has been developed against a deca-citrullinated peptide [59]. Pools of plasma from
five individual animals (5 × 20 µL) and, correspondingly, EV isolates from the same five
individual animals (5 x 20 µL EVs) were used for F95 enrichment, which was performed at
4 ◦C overnight, using a rotating platform. Elution of deiminated (F95-bound) proteins from
the columns was performed with the elution buffer provided with the immunoprecipitation
kit and according to the manufacturer’s instructions (Merck), and the protein eluate was
thereafter diluted 1:1 in 2× Laemmli sample buffer (BioRad, Watford, UK). Samples were
kept frozen at −20 ◦C until further use for SDS-PAGE analysis, Western blotting and in-gel
digestion for LC–MS/MS analysis, as described below.
2.5. Western Blotting Analysis
For Western blotting, SDS-PAGE was carried out on plasma, as well as plasma EV
samples. All samples were diluted 1:1 in denaturing 2× Laemmli sample buffer (containing
5% beta-mercaptoethanol, BioRad, UK) and heated for 5 min at 100 ◦C. Protein separation
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was carried out using 4–20% gradient TGX gels (BioRad UK), followed by Western blotting
at 165 V for 1 h on a Trans-Blot® SD semi-dry transfer cell (BioRad, UK). Membranes were
stained with PonceauS (Sigma, UK) to assess even protein transfer and then blocked with
5% bovine serum albumin (BSA, Sigma, UK) in Tris-buffered saline (TBS) containing 0.1%
Tween20 (BioRad, UK; TBS-T) for 1 h at room temperature. Primary antibody incubation
was carried out overnight at 4 ◦C on a shaking platform using the following antibodies
for reindeer plasma: F95 pan-deimination antibody (MABN328, Merck; diluted 1/1000 in
TBS-T) and anti-human PAD2 (ab50257, Abcam, diluted 1/1000 in TBS-T), PAD3 (ab50246,
diluted 1/1000 in TBS-T) and PAD4 (ab50332, diluted 1/1000 in TBS-T) antibodies, for
detection of putative PAD protein homologues. PAD2 is considered the most conserved
PAD isozyme and the anti-human PAD2 antibody was previously shown to cross-react with
PADs across taxa [17–25,28,29,60,61], while both the PAD3 and PAD4 antibodies have also
been found to cross react with other species, including bird, reptile and bovine [18,20,60].
EV-cargo was also assessed for PAD2, PAD3 and PAD4 as well as deiminated proteins (F95).
For characterization of reindeer plasma EVs, the EV-markers CD63 (ab216130, Abcam, UK)
and Flotillin-1 (ab41927); diluted 1/1000 in TBS-T) were used, and both have previously
been shown to cross-react with EVs from other taxa, besides human. Following primary
antibody incubation overnight at 4 ◦C, the nitrocellulose membranes were washed at RT in
TBS-T for 3 × 10 min and thereafter incubated with HRP-conjugated secondary antibodies
(anti-rabbit IgG, BioRad; or anti-mouse IgM, BioRad, respectively, diluted 1/3000 in TBS-T),
for 1 h at RT. The membranes were then washed for 4 × 10 min TBS-T, followed by one
wash in TBS without Tween20 and digitally visualized, using enhanced chemiluminescence
(ECL, Amersham, UK) in conjunction with the UVP BioDoc-ITTM System (Thermo Fisher
Scientific, Dartford, UK).
2.6. Silver Staining
SDS-PAGE (using 4–20% gradient TGX gels, BioRad, UK) was carried out under
reducing conditions for the F95-enriched protein eluates from both whole plasma and
plasma EVs. The gels were then silver stained using the BioRad Silver Stain Plus Kit
(1610449, BioRad, UK), according to the manufacturer’s instructions.
2.7. Liquid Chromatography with Tandem Mass Spectrometry (LC–MS/MS) Analysis of
Deiminated Protein Candidates
Liquid chromatography with tandem mass spectrometry (LC–MS/MS) was carried
out to identify deiminated proteins from reindeer plasma and plasma EVs (pool of n = 5
deer for plasma as well as plasma EVs, using the isolates from the same animals), according
to previously described methods in other taxa [17,19,20]. Before LC–MS/MS analysis, the
F95-enriched protein preparations (diluted 1:1 in 2× Laemmli buffer and boiled for 5 min
at 100 ◦C) were run 0.5 cm into a 12% TGX gel (BioRad, UK). The concentrated protein
band (containing the F95 eluate) was excized, trypsin digested and subjected to proteomic
analysis using a Dionex Ultimate 3000 RSLC nanoUPLC (Thermo Fisher Scientific Inc.,
Waltham, MA, USA) system in conjunction with a QExactive Orbitrap mass spectrometer
(Thermo Fisher Scientific Inc, Waltham, MA, USA). Peptide separation was performed using
reverse-phase chromatography (flow rate 300 nL/min) and a Thermo Scientific reverse-
phase nano Easy-spray column (Thermo Scientific PepMap C18, 2 µm particle size, 100 A
pore size, 75 µm i.d. × 50 cm length). Peptides were loaded onto a pre-column (Thermo
Scientific PepMap 100 C18, 5 µm particle size, 100 A pore size, 300 µm i.d. × 5 mm length)
from the Ultimate 3000 autosampler (0.1% formic acid for 3 min, flow rate 10 µL/min).
Thereafter, peptides were eluted from the pre-column onto the analytical column. The
linear gradient employed was 2–40% solvent B (80% acetonitrile, 20% water + 0.1% formic
acid) for 30 min. An Easy-Spray source (Thermo Fisher Scientific Inc.) was used to spray
the LC eluant into the mass spectrometer. An Orbitrap mass analyzer (set at a resolution
of 70,000) was used to measure all m/z values of eluting ions, scanned between m/z 380
and 1500. Fragment ions were automatically isolated and generated using data-dependent
scans (Top 20) by higher-energy collisional dissociation (HCD, NCE: 25%) in the HCD
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collision cell. The resulting fragment ions were measured using the Orbitrap analyzer set
at a resolution of 17,500. Singly charged ions and ions with unassigned charge states were
excluded from selection for MS/MS, employing a dynamic exclusion window of 20 s. The
data were processed post-run, using Protein Discoverer (version 2.1., Thermo Scientific).
All MS/MS data were converted to mgf files. The files were submitted to the Mascot search
algorithm (Matrix Science, London, UK) to identify deiminated protein hits. Search was
conducted against a common UniProt database against Artiodactyla (CCP_ Artiodactyla
Artiodactyla_20201013; 840,112 sequences; 473,198,619 residues). An additional search
was conducted against a common contaminant database (cRAP 20190401; 125 sequences;
41,129 residues). The fragment and peptide mass tolerances were set to 0.1 Da and 20 ppm,
respectively. The significance threshold value was set at of p < 0.05 and a peptide cut-off
score of 46 for the common Artiodactyla database (carried out by Cambridge Proteomics,
Cambridge, UK).
2.8. Protein–Protein Interaction Network Analysis
To predict and identify putative protein–protein interaction networks associated
with the deiminated proteins from reindeer plasma and plasma EVs, STRING analysis
(Search Tool for the Retrieval of Interacting Genes/Proteins; https://string-db.org/) was
performed. Protein networks were generated based on protein names and applying the
function of “search multiple proteins” in STRING (https://string-db.org/) using the Artio-
dactyla protein database. For a representative choice of a Artidoactyla protein database, Bos
taurus was selected, as no species-specific Rangifer tarandus protein database is available in
STRING, and within Artiodactyla the highest protein hit match was found with Bos taurus.
Parameters applied in STRING were “basic settings” and “medium confidence”. Nodes are
connected with color lines which represent the following evidence-based interactions for
the network edges: “known interactions” (these are based on experimentally determined
curated databases), “predicted interactions” (these are based on gene neighborhood, gene
co-occurrence, gene fusion, via text mining, protein homology or co-expression). Gene
ontology (GO) and KEGG (Kyoto Encyclopedia of Genes and Genomes) pathways for the
deiminated protein networks were furthermore assessed in STRING and are highlighted
by color coding (for each network analysis figure, please see the corresponding color code
key included for the individual nodes and connective lines).
2.9. Neighbor-Joining Tree Construction for PADs from Deer
To reconstruct a phylogeny tree for Artiodactyla PADs, protein sequences of known
and previously reported PAD isozymes from several deer were compared with other
mammals. No PAD protein sequences have been reported for reindeer in open protein
databases. For reconstruction of a neighbor joining tree, PAD sequences were therefore
used from white-tailed deer (Odocoileus virginianus texanus), red deer (Cervus elaphus hip-
pelaphus) and cow (Bos taurus) and compared with human PADs. The following sequences
were used for the neighbor joining tree construction (using Clustal Omega https://www.
ebi.ac.uk/Tools/msa/clustalo/): Odocoileus virginianus texanus PAD1 (XP_020733655.1),
PAD2 (XP_020733656.1), PAD3 (XP_020733658.1), PAD4 (XP_020754850.1) and PAD6
(XP_020754849.1) isozymes; Bos taurus PAD1 (NP_001094742.1), PAD2 (NP_001098922.1),
PAD3 (XP_010800991.1), PAD4 (NP_001179102.1), and PAD6 (XP_002685843.1) isozymes;
Cervus elaphus hippelaphus PAD1 (OWK12974.1), PAD4 (OWK12644.1) isozymes, human
(Homo sapiens) PAD1 (NP_037490.2), PAD2 (NP_031391.2), PAD3 (NP_057317.2), PAD4
(NP_036519.2) and PAD6 (NP_997304.3). A neighbor-joining phylogeny tree was con-
structed following sequence alignment, and homology of deer PADs between human and
deer was determined by percent identity matrix, using Clustal Omega (https://www.ebi.
ac.uk/Tools/msa/clustalo/).
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2.10. Statistical Analysis
Generation of NTA curves was carried out using the Nanosight 3.0 software (Malvern,
UK). The NTA curves show mean (black line) and standard error of mean (SEM), and the
confidence intervals are indicated (red line). Protein–protein interaction networks were
generating using STRING (https://string-db.org/), applying basic settings and medium
confidence. Significance was considered as p ≤ 0.05.
3. Results
3.1. Characterization of Reindeer Plasma EVs
The NanoSight NS300 was utilized for NTA assessment of particle numbers and size
distribution of reindeer plasma EVs. These were found to be poly-dispersed in the size
range of 40–500 nm, with the majority of the EVs in the size range of 100–250 nm (Figure 1A).
Transmission electron microscopy (TEM) confirmed EV morphology (Figure 1B) and West-
ern blotting confirmed positive signal with two phylogenetically conserved EV-specific
markers, CD63 and Flot-1 (Figure 1C). EV yield from plasma of the different individ-
uals showed some variability within the range of 4.72 × 109–3.11 × 1010 particles/mL
(Figure 1D) and modal EV size was in the range of 110–156 nm (Figure 1E).
Figure 1. Plasma EV profiling of Rangifer tarandus. (A) Nanoparticle tracking analysis (NTA) showing a poly-dispersed
distribution of reindeer plasma EVs in the size range of 30–400 nm, from three representative animals, showing some
individual variation. (B) Transmission electron microscopy (TEM) analysis of EVs derived from reindeer’s plasma; the scale
bar in all images represents 50 nm. (C) Western blotting analysis (WB) showing reindeer plasma EVs positive for CD63 and
Flot-1; the molecular weight standard is indicated in kilodaltons (kDa). (D) Scatter plot representing EV number in reindeer
plasma, showing some variation in plasma EV concentration between animals (n = 16). (E) Modal size of EVs in plasma of
individual animals indicates some individual variation, with modal plasma EV size in the range of 110–150 nm, similar as
seen in the NTA graphs in A; (n = 16). Error bar in D and E represents standard deviation (SD).
3.2. PAD Protein Homologue and Deiminated Proteins in Reindeer Plasma and Plasma EVs
Anti-human PAD2-, PAD3- and PAD4-specific antibodies were used in Western blot-
ting for assessment of putative PAD protein homologues in reindeer, based on cross-
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reaction. A positive protein band at the expected approximate 70–75 kDa size was identi-
fied for all three isozymes in plasma; in plasma EVs only PAD4 was positive, while neither
PAD2 nor PAD3 where detected in plasma EVs (Figure 2A,B). To assess the presence of
total deiminated proteins in plasma and plasma EVs, the F95-enriched fractions were silver
stained, revealing protein bands between 25–250 kDa in plasma and 50–150 kDa in plasma
EVs, respectively (Figure 2C).
Figure 2. Peptidylarginine deiminase (PAD) isoforms and deiminated proteins in reindeer plasma and plasma EVs.
(A) Positive bands identified in reindeer plasma at expected size range of approximately 70–75 kDa using anti-human PAD2-
, PAD3- and PAD4-specific antibodies (a pool of five plasma is represented). (B) In plasma EVs, PAD2 and PAD3 isozymes
were not detected while a strong positive reaction for PAD4 was observed (EV pool from five animals). (C) F95-enriched IP
fractions, representative of deiminated protein enrichment and isolated from reindeer plasma and plasma EVs, were stained
with silverstaining following SDS-PAGE in 4–20% TGX gels. The protein size standard (std) is indicated on the blots and
gels in kilodaltons (kDa).
Sequence alignment, followed by neighbor joining tree construction comparing known
PAD isozyme sequences from deer (white-tailed deer, red deer) with cattle (Bos taurus) and
human (Homo sapiens) PADs, further revealed that deer PAD isozymes align with other
mammalian PADs (Figure 3). Based on percent identity matrix (using Clustal Omega 2.1),
homology of PAD isozymes from deer (using the protein sequences from Odocoileus virgini-
anus texanus) compared with human PADs was as follows: PAD1 78.88%, PAD2 93.29%,
PAD3 87.71%, PAD4 75.97%, and PAD6 71.55%.
3.3. LC–MS/MS Analysis of Deiminated Proteins in Reindeer Plasma and Plasma EVs
Identification of deiminated proteins in reindeer plasma and plasma EVs was carried
out following F95 enrichment using LC–MS/MS analysis. Deiminated protein hits identi-
fied in EVs, showing both hits with R. tarandus and other Artiodactyla, are presented in
Table 1 (for full detailed LC–MS/MS data on F95-enriched proteins from plasma EVs, see
Supplementary Table S1). Deiminated protein hits identified in whole plasma, showing
both hits with R. tarandus and other Artiodactyla, are presented in Table 2 (for full de-
tailed LC–MS/MS data on F95-enriched proteins from whole plasma, see Supplementary
Table S2). The number of deiminated protein hits identified in whole plasma and plasma
EVs from Tables 1 and 2, as well as overlapping hits, are presented in the Venn diagram in
Figure 4A.
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Figure 3. Phylogeny tree of known PADs from Artiodactyla, compared with human. White-tailed deer (Odocoileus
virginianus texanus), red deer (Cervus elaphus hippelaphus) and cow (Bos taurus) peptidylarginine deiminase (PAD) isozymes
were compared with human PADs. The following sequences were used for the neighbor joining tree construction (using
Clustal Omega): Odocoileus virginianus texanus PAD1 (XP_020733655.1), PAD2 (XP_020733656.1), PAD3 (XP_020733658.1),
PAD4 (XP_020754850.1) and PAD6 (XP_020754849.1) isozymes; Bos taurus PAD1 (NP_001094742.1), PAD2 (NP_001098922.1),
PAD3 (XP_010800991.1), PAD4 (NP_001179102.1) and PAD6 (XP_002685843.1) isozymes; Cervus elaphus hippelaphus PAD1
(OWK12974.1) and PAD4 (OWK12644.1) isozymes; human (Homo sapiens) PAD1 (NP_037490.2), PAD2 (NP_031391.2), PAD3
(NP_057317.2), PAD4 (NP_036519.2) and PAD6 (NP_997304.3) isozymes. The numbers next to the species names represent a
measure of support for the node.
Table 1. Deiminated proteins in plasma EVs of reindeer (R. tarandus), identified by F95 enrichment and liquid chromatog-
raphy with tandem mass spectrometry (LC–MS/MS) analysis. Proteins identified only in plasma EVs (and not in whole
plasma) are highlighted in blue and with an asterix (*); uncharacterized hits with a secondary hit that was annotated are
included and indicated in brackets. Protein ID, protein name, species hit with the Artiodactyla UniProt database, number
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† Ions score is −10*Log(P), where P is the probability that the observed match is a random event. Individual ions scores > 46 indicate
identity or extensive homology (p < 0.05). Protein scores are derived from ions scores as a non-probabilistic basis for ranking protein hits.
Biology 2021, 10, 222 14 of 36
Table 2. Deiminated proteins in whole plasma of reindeer (Rangifer tarandus) identified by F95 enrichment and liquid
chromatography with tandem mass spectrometry (LC–MS/MS) analysis. Proteins identified only in whole plasma (and
not in plasma EVs) are highlighted in pink and with an asterix (*); uncharacterized hits with a secondary hit that was
annotated are included and indicated in brackets. Protein ID, protein name, species hit with the Artiodactyla UniProt
database, number of matches and total score are included in the table. For full detailed LC–MS/MS data on F95-enriched
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† Ions score is −10*Log(P), where P is the probability that the observed match is a random event. Individual ions scores > 46 indicate
identity or extensive homology (p < 0.05). Protein scores are derived from ions scores as a non-probabilistic basis for ranking protein hits.
Protein hits identified to be deiminated showed 15 shared identified protein hits in
plasma and plasma EVs; these were albumin, serum albumin, IF rod domain, keratin, ker-
atin 75, keratin, type I cytoskeletal 15, bradykinin, TAF domain-containing protein, histone
H4, annexin, junction plakoglobin, VH region, Ig-like domain, endoplasmic reticulum
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chaperone and obscurin. For whole plasma, 110 hits were identified as specific, while
14 deiminated protein hits were identified to be specific to EVs only (Figure 4A; for identifi-
cation of specific hits, see highlighted proteins in Tables 1 and 2). EV-specific hits included
keratins (KRT5, KRT17, KRT19), collagen (type I alpha-1 and alpha 2 chain; type III alpha-1
chain and isoform X1), SH3 domain-containing protein, cytoplasmic actin 1, endoplasmic
reticulum chaperone BiP, HATPase c domain-containing protein, ubiquitin-60S ribosomal
protein L40, lysozyme, and histone H2B (although a H2B-like protein did also come up as
a possible secondary hit for an uncharacterized hit in whole plasma).
Upon protein network analysis for deimination-enriched proteins in whole plasma
and plasma EVs, a number of shared and unique GO molecular function, GO biological
processes and KEGG pathways were identified as represented by the Venn diagrams in
Figure 4B.
Figure 4. Deiminated protein hits identified in reindeer plasma and plasma EVs. (A) Venn diagram showing deiminated
protein hits identified in R. tarandus whole plasma and plasma EVs, representing shared and unique proteins hits (un-
characterized hits are indicated in brackets). (B) Venn diagrams showing GO pathway analysis for deiminated proteins
identified in plasma and plasma EVs, respectively. The number of Molecular function pathways, Biological Processes and
KEGG pathways, which were found enriched in R. tarandus whole plasma and plasma EVs, respectively, as well as shared
pathways between whole plasma and plasma EVs, are indicated.
3.4. Protein–Protein Interaction Network Identification of Deiminated Proteins in Reindeer Plasma
and Plasma EVs
For the prediction of protein–protein interaction networks of the deimination can-
didate proteins identified in plasma as well as plasma EVs, the protein names were sub-
mitted to STRING (Search Tool for the Retrieval of Interacting Genes/Proteins) analysis
(https://string-db.org/). A functional protein network analysis was carried out as follows:
Protein interaction networks were built based on known and predicted interactions and
represent all deiminated proteins identified in R. tarandus plasma and plasma EVs, respec-
tively. The interaction networks were based on proteins from the STRING protein database
for Bos taurus as a representative species for the Phylum Artiodactyla and for a maximum
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number of hits, as protein identifiers for R. tarandus are not available in the STRING. Protein
interaction networks enriched in deiminated proteins are represented below for plasma
EVs and total plasma, respectively (Figure 5A,B). For both networks, the PPI enrichment
p-value was found to be p < 1.0 × 10−16, which indicates that these proteins are biologically
connected as a group and show more interactions among themselves than what would be
expected for a random set of proteins of similar size, drawn from the genome.
Figure 5. Protein–protein interaction networks of deiminated proteins identified in reindeer plasma EVs and in whole
plasma. Protein–protein interaction networks for deiminated proteins in reindeer plasma EVs and whole plasma, based on
known and predicted interactions in Bos Taurus as a representative species for Artiodactyla, using Searching Tool for the
Retrieval of Interacting Genes/Proteins (STRING) analysis. PPI enrichment p-value for both networks is p < 1.0 × 10−16.
(A) Protein networks enriched in deiminated proteins in reindeer plasma EVs; colored nodes represent query proteins only.
(B) Protein networks enriched in deiminated proteins in reindeer whole plasma; colored notes represent query proteins
only. Colored lines connecting the nodes show the type of interactions between the nodes in the networks; this is based on
known interactions, predicted interactions and other (including textmining, co-expression and protein homology); the color
code is provided in the figure.
STRING analysis was further used to identify KEGG pathways (Kyoto Encyclopaedia
of Genes and Genomes pathways) for the deiminated protein candidates in plasma EVs and
whole plasma, and these are highlighted in Figure 6. In plasma EVs, eight KEGG pathways
were identified (Figure 6A), while nine KEGG pathways enriched in deiminated proteins
were identified in whole plasma (Figure 6B); the only common pathway between plasma
EVs and whole plasma was the complement and coagulation pathway (Figure 6). KEGG
pathways identified in EVs were: protein digestion and absorption, platelet activation,
amoebiasis, the AGE–RAGE signaling pathway in diabetic complications, ECM receptor
interaction, the relaxin signaling pathway and the estrogen signaling pathway (Figure 6A).
In whole plasma, deimination-enriched KEGG pathways (in addition to the complement
and coagulation cascade) were: Staphylococcus aureus infection, prion diseases, vitamin
digestion and absorption, pertussis, ferroptosis, SLE, thyroid hormone synthesis and
phagosome (Figure 6B).
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Figure 6. KEGG pathways for deiminated proteins identified in reindeer plasma EVs and whole plasma. Protein–protein
interaction networks identified in reindeer plasma are based on known and predicted interactions in Bos taurus as a
representative Artiodactyla for creation of the protein networks, using Searching Tool for the Retrieval of Interacting
Genes/Proteins (STRING) analysis. (A) KEGG pathways in plasma EVs are highlighted, with eight pathways identified for
the deimination protein networks. (B) KEGG pathways in whole plasma are highlighted; nine pathways were identified
for the deimination protein networks. The color code for the specific KEGG pathways for both networks is indicated in
(A,B), respectively.
Protein networks of deiminated proteins in plasma EVs were also analyzed for GO
biological processes and GO molecular function and STRING protein networks for these
processes are provided in Supplementary Figure S1A,B, respectively. Similarly, whole
plasma deimination STRING protein networks for GO biological processes and GO molec-
ular function are provided in Supplementary Figure S2A,B respectively.
4. Discussion
This is the first study to assess extracellular vesicles (EV) and protein deimination
signatures in reindeer plasma and plasma EVs. The current study aimed to provide novel
insights into roles for post-translational regulation of reindeer immunity and metabolism
while also highlighting putative roles for post-translational deimination in the functional
diversification of conserved protein pathways throughout phylogeny.
Reindeer plasma EVs showed a poly-dispersed population in the size range of
40–500 nm with the majority of EVs falling in the range of 100–250 nm, which is a similar
size distribution as previously described for Bos taurus plasma EVs [20], and similar as
observed for human EVs. Reindeer plasma EVs showed positive for the phylogenetically
conserved EV-specific markers CD63 and Flotllin-1, and were furthermore verified by
transmission electron miscopy.
PAD isozymes were assessed in both reindeer plasma and plasma EVs by Western blot-
ting, using anti-human PAD2-, PAD3- and PAD4-specific antibodies, revealing the presence
of these three PAD isozymes in reindeer whole plasma at the predicted size of 70–75 kDa
as seen for other mammals, while only PAD4 was shown to be exported in reindeer plasma
EVs. This may be of considerable interest as the different PAD isozymes vary in their speci-
ficity for target proteins, with PAD4 having a narrower target selection than PAD2 [35],
and this may therefore also reflect some of the differences observed in deiminated proteins
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found inside EVs, compared with deiminated proteins in whole plasma. Additionally, in
comparison with previous assessment of alligator plasma EVs, where PAD2 was found
in abundance in EVs, alongside low levels of PAD3 but no PAD4 export the EVs, such
differences in EV-mediated PAD isozyme transport indicates differences in PAD mediated
communication via EVs across animal phyla and may contribute to immune diversity
observed across phylogeny. It must be noted that neither PAD1, which is associated mainly
with skin and skin diseases, or PAD6, which is linked to fertility and pre-implantation
embryo, were assessed in reindeer plasma in the current study.
To identify deiminated protein targets in plasma and plasma EVs of reindeer, F95
enrichment with tandem mass spectrometry was carried out. This analysis revealed some
differences between hits in whole plasma and plasma EV cargo: overall, 110 deiminated
proteins were identified to be specific to whole plasma and 14 deiminated proteins were
identified in plasma EVs only; in addition, 15 deiminated protein hits were found to be
shared between whole plasma and plasma EVs. Further uncharacterized proteins were also
identified in both plasma and plasma EVs. Overall, this indicates differences of deimination
mediated functions in cellular communication via EVs, compared with whole plasma, and
functional protein network analysis for these deiminated protein hits in reindeer plasma
and plasma EVs was therefore performed using STRING analysis. This revealed differences
in deimination enrichment in functional protein networks of Kyoto Encyclopaedia of Genes
and Genomes (KEGG) pathways, as well as Gene Ontology (GO) pathways for biological
processes and molecular functions as discussed below:
KEGG pathways shared for deiminated proteins in whole plasma and plasma EVs
were complement and coagulation pathways. Additional KEGG pathways which were
specific for deiminated proteins in plasma EVs included ECM receptor interaction, platelet
activation, amoebiasis, the estrogen signaling pathway, the AGE–RAGE signaling pathway
in diabetic complications, the relaxin signaling pathway, as well as in protein digestion and
absorption. KEGG pathways specific for deiminated proteins in whole plasma were pertus-
sis, ferroptosis, phagosome, Staphylococcus aureus infection, systemic lupus erythematosus
(SLE), prion disease, thyroid hormone synthesis, vitamin digestion and absorption.
Of interest is that while the complement and coagulation system was identified as
deiminated in both whole plasma and plasma EVs, differences were observed in the target
proteins of deimination which participate in these cascades. In plasma EVs, proteins con-
nected to complement and the coagulation system and identified as deimination candidates
were fibrinogen, kinogenin and bradykinin. The complement system has important roles
in clearing invading pathogens, as well as necrotic and apoptotic cells, and bridges innate
and adaptive immunity [62]. In whole plasma, key complement components including
C1q, C3, C4, C5, C9, as well as factor H and the C3/C5 convertase were identified as deimi-
nated. Deimination of complement components has previously been reported for a various
complement components, including some identified here, in serum and plasma from a
range of species [12–25,29]. Interestingly, in bovine serum-EVs, a number of deiminated
complement components has been identified, including C1q, C3, C4A, C5a, C7, C8, C9
factor B, Factor H, C4-binding protein [20], while in teleost fish serum both C3 and C4
were identified in deiminated form but in teleost serum-EVs C3 was more dominant in
deiminated form, compared with C4 [12,13,16]. This indicates that deimination mediated
regulation of complement-related mechanisms, including via EVs, may differ between
animal species and may possibly also link to different export of PAD isoforms in EVs
between species—also bearing in mind that lower in phylogeny, only one PAD form will
be responsible for all deimination, while in mammals there are more PAD isoyzmes with
target-specific preferences.
In EVs, deimination enrichment for amoebiasis and platelet activation KEGG path-
ways were identified, both of which have also been found deiminated in cattle [20] and
relate to anti-pathogenic and injury responses. The ECM receptor interaction KEGG path-
way was also identified as enriched in deiminated proteins and plays multifaceted roles
(both direct and indirect) in apoptosis, cell adhesion, cell differentiation, migration and
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proliferation. The ECM receptor interaction pathway is also related to anti-bacterial and
anti-viral responses [63,64], as well as cancer [65]; furthermore, deimination enrichment in
this pathway has been identified in brain cancer [50]. The ECM receptor interaction path-
way has been found enriched in deiminated proteins in cattle [20], in long lived and cancer
resistant animals such as whale [14] and long-lived birds such as albatross [25], as well as
in alligator, an animal with unusual anti-bacterial and anti-viral responses [18]. In EVs, the
estrogen signaling pathway was identified to be enriched in deiminated proteins, and this
was also previously observed in bovine plasma EVs [20]. Deimination in estrogen signaling
may be of considerable interest as estrogen receptors are expressed broadly in innate and
adaptive immune-related cells and also affect cytokine production, and are furthermore
involved in immune regulation in the tumour environment [66]. The AGE–RAGE signaling
pathway, also enriched in deiminated proteins in EVs, relates to diabetic complications [67],
age- and stress-related arterial diseases [68] as well as playing multifaceted roles in cancer
progression, including cell death control (apoptosis, autophagy and necroptosis), cytokine
release and EMT, including in chronic mucosal inflammation [69–71]. Deimination enrich-
ment in the relaxin signaling pathway was also identified to be specific to plasma EVs.
This may be of considerable interest as relaxin mediates a range of biological functions
including anti-apoptotic, anti-fibrotic, angiogenic, vasodilatory and anti-inflammatory
responses [72]. Metabolic-related KEGG pathway identified as enriched in deiminated
proteins for plasma EVs was for protein digestion and absorption. As the regulation of
protein metabolism in ruminants has been studied due to importance in farming [73],
putative signaling regulation in this pathway via deimination may be of some interest.
In plasma, the specific deimination-enriched KEGG pathways, besides complement
and coagulation cascade, related to both immunity and metabolism. Immune-related KEGG
pathways were ferroptosis, phagosome, pertussis, Staphylococcus aureus infection, systemic
lupus erythematosus (SLE) and prion disease. This indicates a number of deimination-
regulated pathways involved both in antimicrobial responses as well as autoimmunity and
neurodegeneration. Cell death via ferroptosis is an iron-dependent process which occurs
via iron accumulation and lipid peroxitation, resulting in oxidative cell death and related to
a range of pathological processes, including nervous system disease, ischemia-reperfusion
and cancer [74,75]. Therefore, insights into roles for deimination may be of considerable
interest in this type of cell death. SLE is a known deimination-related autoimmune disease,
alongside a number of other connective tissue autoimmune diseases [76], and therefore
enrichment in autoimmune pathways was not unexpected. Similarly, prion diseases have
been linked to deimination and are further discussed in detail below. Metabolic pathways
enriched in deiminated proteins in plasma were thyroid hormone synthesis and vitamin
digestion and absorption. The thyroid hormone synthesis pathway plays roles in the
regulation of metabolism and energy homeostasis, regulation of insulin and thermogenesis,
and is also linked to stress [77,78], alongside a range of pathologies including cancer,
obesity, dyslipidemia, degenerative brain disease and dementia [79]. Regulation of the
thyroid hormone synthesis pathway via epigenetic modifications of histones has also been
reported [80] and this pathway has previously been linked to deimination enrichment in
whales [14]. Furthermore, PADs and deimination have been linked to autoimmune thyroid
disease and thyroid cancer [81,82]. Deimination enrichment in the vitamin digestion and
absorption pathway may furthermore contribute to diverse roles of vitamin processing,
which in reindeer is critical as they have undergone adaptions for vitamin D metabolism [1],
and indeed vitamin D-binding protein was identified as a deimination candidate in whole
plasma. Interestingly, vitamin D-binding protein has also been identified as a deimination
candidate in camelids [19], which are also metabolically adapted to extreme environments.
Numerous GO biological pathways were furthermore identified in plasma and plasma
EVs (Supplementary Figures S1A and S2A), with 257 pathways in plasma and 48 in EVs,
while 17 were shared between plasma and plasma EVs. Shared pathways were: tricovalent
inorganic cation transport, blood coagulation, cytolysis, regulation of body fluid levels,
response to alcohol, iron ion homeostasis, digestion, negative regulation of developmental
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process, metal ion transport, iron ion transport, platelet activation, negative regulation of
multicellular organismal process, metal ion homeostasis, positive regulation of multicellular
organismal process, response to endogenous stimulus, response to abiotic stimulus.
Molecular function GO pathways identified for F95-enriched proteins and shared for
whole plasma and plasma EVs (Supplementary Figures S1B and S2B) were: metal ion bind-
ing, identical protein binding, cysteine-type endopeptidase inhibitor activity, serine-type
endopeptidase activity and structural molecule activity. In whole plasma, 42 GO molecular
pathways were identified for deiminated proteins, 5 of which were shared with EVs. Molec-
ular GO pathways specific for deiminated proteins in EVs were: the platelet-derived growth
factor-binding pathway, extracellular matrix structural constituent, pyridoxal phosphate
binding, protease binding and protein binding (Supplementary Figures S1 and S2).
Deimination enrichment in the various metabolic and immune-related pathways
identified here may be of considerable relevance for physiological and pathobiological
processes in reindeer. Importantly, reindeer have undergone a number of immune as well
as metabolic adaptions, including for fat metabolism processes, limited heat loss and low
resting metabolic rate, as well as changes to their internal biological clock [1,2]. Compar-
ative genome analysis of reindeer has identified specifically adopted factors involved in
immunity, vitamin D metabolism, retinal development, circadian rhythm, tolerance to
cold-triggered pain and antler development [1]. Indeed, we identified deimination enrich-
ment in numerous metabolic pathways, including vitamin and lipid metabolic pathways
such as vitamin digestion and absorption, regulation of lipoprotein, lipid metabolism,
cholesterol transport and efflux, fatty acid biosynthesis, regulation of ketone metabolic
processes, lipid and vitamin binding. Other deimination-enriched pathways included
protein digestion and absorption, the estrogen signaling pathway and thyroid hormone
synthesis, as discussed above. Interestingly also, some differences were again observed
between whole plasma and plasma EVs, indicating some differences in cellular commu-
nication in metabolic processes relating to EVs, as listed above (see also Supplementary
Figures S1 and S2 for GO biological and GO molecular pathways).
A large number of pathways relating to defense and stress responses, innate and adap-
tive immunity, including the activation and regulation of immunity, humoral antimicrobial
immunity, response to bacterium and parasites, complement-related functions, apoptosis
and phagocytosis, iron metabolism, cytokine regulation as well as symbiosis, were here
among many other immune-related pathways found to be enriched in deiminated proteins
(Figure 6; Supplementary Figures S1 and S2). Furthermore, histones, which are known to
act as anti-pathogenic agents. were here found to be deiminated in plasma and plasma
EVs. While mainly histone H3 deimination has been studied in anti-pathogenic responses
relating to extracellular trap formation (NETosis/ETosis), roles for antimicrobial effects
of H2 and H4 histones has also been established, including anti-viral ones [83]. Their
deimination in anti-pathogenic responses remains to be further investigated, but has been
linked to gene regulatory events, including in cancer [84]. In plasma, a number of ser-
pins were identified to be deiminated. These serine proteinases have multifaceted roles
in protease inhibition, chromatin organization, hormone transport, control of apoptosis,
as well as in anti-microbial and anti-viral responses [85–88]. Overall, our findings point
to roles for deimination in immune response modulation, possibly allowing for protein
moonlighting in health and disease and in response to various pathogenic infections via
this post-translational modification. Indeed, reindeer have been widely studied in relation
to a number of naturally occurring infections including parasitic bacterial and viral ones
and are also related to a range of zoonotic diseases [8]; these are summarized below:
With respect to parasitic infections, more than 100 parasite species have been reported
to infect or infest reindeer [89–94], many of which are also shared with other ruminants.
Protozoan parasites include Eimeria species [95], Cryptosporidium and Giardia [96], Enta-
moeba [97], Besnoitia [98,99] and Toxoplasma gondii [100–103]. Reindeer in Fennoscandia are
intermediate hosts for Sarcocystis spp. [104,105]. Haematozoan parasites include Babesia spp.
and Trypanosoma spp. [94]. The rumen fluke Paramphistomum leydeni and the liver fluke
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Dicrocoelium dendriticum (Trematoda) also infect reindeer [106,107]. Furthermore, a number
of Cestoda paraitize reindeer, acting either as intermediate or final hosts [91,108–110]. Ne-
matoda form the most common and versatile group of parasites in reindeer and are most
often associated with intestine [91,93,107,111–115], but can also be found in the capillaries
of the ears and eyelids [116,117], or be bloodborne [118]. Some nematodes are also confined
to the central nervous system (CNS) and can cause paralysis; a major concern in rein-
deer breeding [119], while others affect the lung [91,120,121]. Additionally, the arthropod
sinus worm Linguatula arctica is widespread and common parasite of reindeer [91,122]
and ectoparasites also infest reindeer [67], causing skin and mucosal swelling, bleeding
and affect breathing [91,123–125]. Importantly, parasitic infections from reindeer can also
be zoonotic, for example Enterocytozoon bieneusi—a microsporidia and obligate parasite
infecting intestinal cells, is suggested to be transmitted to humans [126].
A number of naturally occurring viral infections have also been identified in reindeer,
including alphaherpesvirus, bluetongue virus, malignant catarrhal fever (MCFV-)-related
gammaherpesvirus, pestivirus, Schmallenberg virus [7,8,127–129], West Nile virus which
leads to lymphohistiocytic encephalomyelitis [7] and tick-borne encephalitis virus (TBEV),
which belongs to the most important neurological pathogens transmitted by tick bites in
Europe [130]. Further viruses include papillomaviruses, parvovirus, and polyomavirus,
as well as importantly also Coronaviridae [131]. Experimental viral infections in reindeer
include herpesvirus 2 and parapoxvirus, both of which have though also been detected
in Norwegian reindeer [129], including semi-domesticated reindeer [132] as well as in
Alaskan caribou and other wildlife, and are known to be transmitted between wildlife,
sheep, goats and human [5].
Importantly, the white-tailed deer (Odocoileus virginianus) has recently been proven to
be experimentally infected via intranasal inoculation with SARS-CoV-2, showing evidence
of subclinical viral infection as well as shedding of infectious virus in nasal secretions and
feces, as well as detection of viral RNA in multiple tissues [9]. These findings point to
deer as a putative new zoonotic host for the virus, although it still needs to be further
established whether the infection will also happen naturally, and therefore contribute as a
novel viral reservoir [9]. Whether there is a possibility of zoonotic transmission from deer
back to humans, as recently observed in mink [133–135], also needs to be established, as
well as if other Cervidae, including reindeer, can act as zoonotic hosts and reservoirs for
SARS-CoV-2. Furthermore, it must be considered that reindeer do come in close contact
with sheep through shared grounds for grazing, and may also encounter other domestic
or wild animals on shared habitats elsewhere, and this could possibly be another concern
regarding zoonosis spread.
Bacterial infections described in reindeer include Anaplasma phagocytophilum, which
in sheep and cattle causes tick-borne fever and can in human cause the zoonotic disease
granulocytic anaplasmosis [8]. Evidence for transmission of Lyme disease, which is caused
by Borrelia bugdorferi, a tick-borne encephalitis associated bacterium, has furthermore been
described from reindeer to human following skinning of a reindeer, causing meningoen-
cephalitis [6]. Reindeer are also subject to tuberculosis, caused by Mycobacterium bovis [136],
as well as polymicrobial bronchopneumonia caused by Mycoplasma ovipneumoniae [137].
Brucella spp., is a zoonotic bacteria that is one of the most widespread and economically
impactful zoonosis affecting reindeer and can be transmitted to human via raw animal
products, including from reindeer and caribou [138,139]. Anthrax, a global zoonotic and
epizoonotic disease, is another bacterial pathogen identified in reindeer, particularly in
relation to infected carcasses, as recently found in Siberian permafrost and therefore also
indicative of a possible rise in the Arctic due to climate change [140]. Reindeer have in
addition been found to carry Clostridium perfringens [141] and can suffer from severe bacte-
rial intestinal infections and endotoxemia by Clostridium sp [142,143], while other bacteria
inside the order Clostridiales aid in processing of lichen secondary metabolites [144]. Rein-
deer also carry Erysipelothrix rhusiopathiae- which relates to urticaria-like lesions, arthralgia,
arthritis, endocarditis and sepsis and can furthermore be transmitted to humans [145]. This
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may be of interest as both bacterial and autoimmune disease pathways were here identified
to be linked to deiminated proteins in reindeer plasma via STRING analysis.
The strong relationship of deimination-enriched proteins with a number of immune-
related pathways may therefore be important in relation to the infections listed above, both
naturally occurring ones as well as zoonotic ones. It also has to be considered that PADs are
phylogenetically conserved proteins which are also found in bacteria and parasites, both of
which can use their PAD homologues to manipulate host immunity [39,40]. Therefore the
interplay of host–pathogen post-translational regulation is a field which requires further
investigation.
Importantly, in the current study, deimination-enriched pathways were also identified
for prion disease and amyloid in whole plasma. This is indicative of that deimination
plays roles in prion diseases in reindeer. Deer are well known to be affected by prion-
related transmissible spongiform encephalopathy, a neurodegenerative disease which
in reindeer manifests as chronic wasting disease (CWD), and is also found in deer, elk
and moose [4,146,147]. Its transmission is believed to be primarily transmitted via direct
contact of oral and mucosal membranes between positive and susceptible animals, also
via feces and urine, as well as prion reservoirs in soil and water [148,149]. In white
tailed deer, differential gene expression analysis for CWD has identified links to various
cellular components, as well as retroviral infection [150]. Previous studies have indeed
related protein deimination to prion disease including Creutzfeldt-Jacob Disease and
scrapie [151–155], via effects on prion conformation, enolase, protein accumulation and
pathogenesis, although further in depth examination into exact mechanistic pathways is
still needed. Furthermore, a recent animal study on early pre-motor Parkinson’s disease
(PD) identified enrichment of deiminated proteins in pathways relating to prion disease in
the PD, versus control animals [156], further highlighting deimination as a common factor
in various neurodegenerative disorders, including prion diseases. It may therefore be of
considerable importance that deimination was identified here also in prion disease-related
pathways in reindeer as this shows conserved pathways across phyla. Furthermore, the
disease is spreading geographically including in the US, Canada, Scandinavia and South
Korea [147] and therefore understanding underlying pathways to develop measures for
reducing transmission between animals, including domestic ones such as cattle, sheep and
swine, as well as possible transmission to human, including via consumption of infected
deer and elk, is of considerable importance [149,157–160].
It must be noted that the analysis of protein networks enriched in deiminated proteins
presented here relied on deimination enrichment using the pan-citrulline-specific F95
antibody, and therefore further evaluation, including that of individual candidate proteins
for deimination and using other citrulline signature proteomic approaches, should also
be considered. The protein networks presented are based on functional protein network
analysis, which besides experimentally established interactions also takes into account
indirect and functional interactions. The protein network analysis is furthermore based
on protein hits identified in the Artiodactyla UniProt database, and using Bos taurus as a
representative species for Artiodactyla, as a species-specific reindeer proteomic database is
not available in STRING. It must also be considered that the current study only assessed
female reindeer that were assessed as healthy, and therefore further investigations into
deimination and EV signatures relating to sex differences and health status remain subject to
further in depth investigations. Nonetheless, this study provides a base line for furthering
understanding of the roles of deimination and EVs in reindeer immunity and metabolism
and may provide a platform for the development of novel biomarkers to assess wild life
health status and zoonotic disease transmission.
5. Conclusions
The current study characterized PAD expression and deiminated protein product
signatures in plasma and plasma extracellular vesicles (EVs) of reindeer (R. tarandus).
Some differences were observed for PAD isozyme PAD2, PAD3 and PAD4 detection in
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whole plasma versus plasma EVs, with only PAD4 being exported in the EVs. Protein
deimination signatures of whole plasma versus plasma EVs confirmed a range of KEGG
and GO pathways relating to key immune and metabolic functions, including pathways
for innate and adaptive immunity, prion disease, as well as hormonal regulation, vitamin
and lipid metabolism. This provides novel insights into the roles for post-translational
protein deimination in the regulation of key pathways involved in physiological and
pathophysiological processes and further links to various known pathways in deer relating
to infection and immunity in pathogenic and prion diseases. Furthermore, deimination
may contribute to various unique adaptions of reindeer immune and metabolic pathways,
which warrants further investigation. Importantly, as reindeer can play roles as reservoir
hosts for a range of pathogens circulating in captive, wild as well as domestic ruminant
species, and be a reservoir for zoonotic disease, including coronaviruses, bacterial and
parasitic ones, the current study provides novel insights into their immune systems, which
may be critically relevant in understanding of zoonosis spread and management.
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